BMC Cancer

official impact factor 3.15

Open Access Highly Access

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

Loukas F Kontovinis, Konstantinos T Papazisis*, Panagiota Touplikioti, Charalambos Andreadis, Despoina Mouratidou and Alexandros H Kortsaris

BMC Cancer 2009, 9:82 doi:10.1186/1471-2407-9-82

Accesses  

  • Last 30 days: 95 accesses
  • Last 365 days: 746 accesses
  • All time: 3885 accesses

Cited by